drugset
drugset / Trial / NCT03677115

Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine

NCT03677115 ↗

Phase 4 Withdrawn China Medical University, China
NaSingle-groupOpen-labelTreatment

Summary

The investigators designed a study to assess whether thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine prolong nerve block duration.

Timeline

Start
2018-11-01
Primary completion
2023-03-30
Completion
2023-03-30

Outcome

Outcome not reported

Stopped (Enrollment): “no participants enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 20 ug Other
Background Ropivacaine Other / unclassified — Other

Indications

No indication recorded.